Inventor · disambiguated record
Gillis Otten
Also filed as: OTTEN GILLIS
24 granted patents·8 pending applications·493 citations·filing 2001–2024
97Inventor score
Files withGLAXOSMITHKLINE BIOLOGICALS SA22GEALL ANDREW3NOVARTIS AG1NOVARTIS VACCINES & DIAGNOSTIC1O' HAGAN DEREK1
Top patents by PatentIndex Score
32 records- 0199US11707482B2Delivery of RNA to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Jul 25, 2023·7 cites·30 claims
- 0299US11690862B1Delivery of RNA to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Jul 4, 2023·7 cites·46 claims
- 0399US11596645B2Delivery of RNA to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Granted Mar 7, 2023·7 cites·103 claims
- 0499US11324770B2Delivery of RNA to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted May 10, 2022·38 cites·114 claims
- 0599US11291682B2Delivery of RNA to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Granted Apr 5, 2022·48 cites·102 claims
- 0699US10532067B2Delivery of RNA to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Jan 14, 2020·66 cites·6 claims
- 0798US11717529B2Delivery of RNA to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Aug 8, 2023·5 cites·46 claims
- 0898US11696923B2Delivery of RNA to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Jul 11, 2023·4 cites·46 claims
- 0998US11690861B2Delivery of RNA to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Jul 4, 2023·5 cites·30 claims
- 1098US11690863B2Delivery of RNA to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Jul 4, 2023·4 cites·46 claims
- 1198US11690865B2Delivery of RNA to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Jul 4, 2023·4 cites·46 claims
- 1298US11058762B2Immunogenic compositions and uses thereofGEALL ANDREW·Filed 2012·Granted Jul 13, 2021·43 cites·21 claims
- 1398US11026964B2Delivery of RNA to different cell typesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Jun 8, 2021·46 cites·18 claims
- 1498US9801897B2Delivery of RNA to trigger multiple immune pathwaysGEALL ANDREW·Filed 2011·Granted Oct 31, 2017·73 cites·14 claims
- 1597US11690864B2Delivery of RNA to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Jul 4, 2023·2 cites·30 claims
- 1697US9770463B2Delivery of RNA to different cell typesGEALL ANDREW·Filed 2011·Granted Sep 26, 2017·73 cites·18 claims
- 1796US11865080B2Delivery of RNA to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Jan 9, 2024·1 cites·30 claims
- 1896US11857562B2Delivery of RNA to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Jan 2, 2024·1 cites·30 claims
- 1996US11759475B2Delivery of RNA to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Sep 19, 2023·1 cites·46 claims
- 2096US11730754B2Delivery of RNA to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Aug 22, 2023·1 cites·30 claims
- 2195US2025302860A1Delivery of rna to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2024·Application pending·0 cites
- 2294US7771979B2Compositions and methods for generating an immune response utilizing alphavirus-based vector systemsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Granted Aug 10, 2010·39 cites·21 claims
- 2392US8647864B2Compositions and methods for generating an immune response utilizing alphavirus-based vector systemsPOLO JOHN M·Filed 2010·Granted Feb 11, 2014·18 cites·21 claims
- 2491US12186333B2Delivery of RNA to trigger multiple immune pathwaysGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2023·Granted Jan 7, 2025·0 cites·9 claims
- 2573US2021268013A1Delivery of rna to different cell typesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Application pending·0 cites
- 2664US2008026071A1Microparticles for delivery of heterologous nucleic acidsO'HAGAN DEREK·Filed 2007·Application pending·0 cites
- 2763US2021290755A1Immunogenic compositions and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Application pending·0 cites
- 2854US2022168413A1Adjuvanted multivalent influenza vaccinesSEQIRUS UK LTD·Filed 2020·Application pending·0 cites
- 2952US2018333406A1Benzonapthyridine compositions and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Application pending·0 cites
- 3050US9597326B2Benzonapthyridine compositions and uses thereofOTTEN GILLIS·Filed 2011·Granted Mar 21, 2017·0 cites·15 claims
- 3146US2003138453A1Microparticles for delivery of heterologous nucleic acidsFiled 2001·Application pending·0 cites
- 3244US2015140068A1Immunogenic compositions and uses thereofNOVARTIS AG·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gillis Otten files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →